Comparison of baseline demographics, comorbidities and treatment variables
| Before, (n=64) | After, (n=30) | p Value | |
|---|---|---|---|
| Age, mean (SD) | 66.6 (15.8) | 66.2 (18.1) | 0.9 |
| Women, n (%) | 33 (51.6) | 16 (53.3) | 0.87 |
| NIHSS, median (IQR) | 16 (10–21) | 18 (11–24) | 0.2 |
| Onset–ER, mean h:min (SD) | 3:00 (2:08) | 3:03 (4:04) | 0.2 |
| IV rt-PA, n (%) | 26 (40.6) | 13 (43.3) | 0.8 |
| DM, n (%) | 22 (34.4) | 7 (23.3) | 0.27 |
| HTN, n (%) | 45 (70.3) | 21 (70) | 0.97 |
| HPL, n (%) | 30 (46.9) | 16 (53.3) | 0.56 |
| AFIB, n (%) | 19 (29.7) | 9 (30) | 0.97 |
| SMK, n (%) | 10 (15.6) | 8 (26.7) | 0.2 |
| Off-hours treatment, n (%) | 28 (43.8) | 16 (53.3) | 0.5 |
| GETA, n (%) | 39 (60.9) | 17 (56.7) | 0.7 |
AFIB, atrial fibrillation; DM, diabetes mellitus; ER, emergency room; GETA, general endotracheal anesthesia, off hours treatment: stroke intervention performed before 7:00 or after 17:00 or at the weekend; HPL, hyperlipidemia; HTN, hypertension; NIHSS, National Institutes of Health Stroke Scale; onset-ER, time from symptom onset to ER arrival; rt-PA, recombinant tissue plasminogen activator; SMK, smoking.